TY - JOUR
T1 - Central Nervous System–Active Medication Use in Older Adults With and Without Dementia—A Retrospective Cohort Study
AU - Nafisseh, Warner
AU - Van Houten, Holly K.
AU - Tung, Ericka E.
AU - Verdoorn, Brandon P.
AU - Warner, David Oman
AU - Mielke, Michelle M
AU - Jeffery, Molly M.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Society of General Internal Medicine 2025.
PY - 2025
Y1 - 2025
N2 - Importance: Central nervous system (CNS)–active medication use is common in older adults; however, there are limited data on utilization trends over time, differences in utilization amongst those with and without dementia, and modification of utilization surrounding dementia diagnosis. Objective: To evaluate CNS-active medication trends in US older adults with and without dementia over 13 years, including evaluation of changes in utilization before and after dementia diagnosis. Design: Retrospective observational cohort study using de-identified administrative claims data. Participants: Older adult (age ≥ 65 years) commercial and Medicare Advantage enrollees with continuous medical and pharmacy coverage for at least one calendar year from 2010 through 2022. Main Measures: (1) Annual probability of receiving CNS-active medications; (2) changes in medication use with dementia diagnosis. Key Results: In total, 6,062,601 enrollees were included; 682,833 (11.3%) with dementia and 5,379,768 (88.7%) without. CNS-active medication use was highest in those with dementia throughout the study time period. Opioid utilization in those with and without dementia was 36.1% and 29.6% in 2010, decreasing to 24.3% and 22.2%, respectively, in 2022. Antidepressant use increased over time (i.e., 45.2 to 52.0% dementia; 15.8 to 24.6% without). Antipsychotic use in those with dementia was 18.1% in 2010, decreased to 15.9% in 2016, and increased back to 18.0% in 2022. A total of 444,587 enrollees experienced incident dementia diagnosis. There were immediate increases in antipsychotic (0.9% [0.5, 1.4] absolute increase, p < 0.001) and antidepressant (4.0% [3.3, 4.6] absolute increase, p < 0.001) use in the month following diagnosis. Increased use of these medications peaked 3–5 years after diagnosis. Dementia diagnosis was associated with decreased slopes of opioid (− 0.2% [− 0.3, − 0.1], p < 0.001) and benzodiazepine (− 0.07% [− 0.11, − 0.03], p < 0.001) use. Conclusions: CNS-active medication use is higher in older adults with dementia when compared to those without dementia. Incident dementia diagnosis is accompanied by marked increases in the use of antidepressants and antipsychotics.
AB - Importance: Central nervous system (CNS)–active medication use is common in older adults; however, there are limited data on utilization trends over time, differences in utilization amongst those with and without dementia, and modification of utilization surrounding dementia diagnosis. Objective: To evaluate CNS-active medication trends in US older adults with and without dementia over 13 years, including evaluation of changes in utilization before and after dementia diagnosis. Design: Retrospective observational cohort study using de-identified administrative claims data. Participants: Older adult (age ≥ 65 years) commercial and Medicare Advantage enrollees with continuous medical and pharmacy coverage for at least one calendar year from 2010 through 2022. Main Measures: (1) Annual probability of receiving CNS-active medications; (2) changes in medication use with dementia diagnosis. Key Results: In total, 6,062,601 enrollees were included; 682,833 (11.3%) with dementia and 5,379,768 (88.7%) without. CNS-active medication use was highest in those with dementia throughout the study time period. Opioid utilization in those with and without dementia was 36.1% and 29.6% in 2010, decreasing to 24.3% and 22.2%, respectively, in 2022. Antidepressant use increased over time (i.e., 45.2 to 52.0% dementia; 15.8 to 24.6% without). Antipsychotic use in those with dementia was 18.1% in 2010, decreased to 15.9% in 2016, and increased back to 18.0% in 2022. A total of 444,587 enrollees experienced incident dementia diagnosis. There were immediate increases in antipsychotic (0.9% [0.5, 1.4] absolute increase, p < 0.001) and antidepressant (4.0% [3.3, 4.6] absolute increase, p < 0.001) use in the month following diagnosis. Increased use of these medications peaked 3–5 years after diagnosis. Dementia diagnosis was associated with decreased slopes of opioid (− 0.2% [− 0.3, − 0.1], p < 0.001) and benzodiazepine (− 0.07% [− 0.11, − 0.03], p < 0.001) use. Conclusions: CNS-active medication use is higher in older adults with dementia when compared to those without dementia. Incident dementia diagnosis is accompanied by marked increases in the use of antidepressants and antipsychotics.
UR - http://www.scopus.com/inward/record.url?scp=105000559531&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105000559531&partnerID=8YFLogxK
U2 - 10.1007/s11606-025-09454-1
DO - 10.1007/s11606-025-09454-1
M3 - Article
AN - SCOPUS:105000559531
SN - 0884-8734
JO - Journal of general internal medicine
JF - Journal of general internal medicine
ER -